Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-13 4:05 pm Purchase |
2025-06-09 | 13G | ReShape Lifesciences Inc. RSLS |
L1 Capital Global Opportunities Master Fund, Ltd. | 235,000 9.850% |
235,000 (New Position) |
Filing History |
| 2025-05-14 2:59 pm Purchase |
2025-03-31 | 13G | ReShape Lifesciences Inc. RSLS |
Ayrton Capital LLC | 200,000 5.710% |
200,000 (New Position) |
Filing History |
| 2025-05-12 12:11 pm Sale |
2025-03-31 | 13G | ReShape Lifesciences Inc. RSLS |
CVI Investments, Inc. | 200,000 5.700% |
-144,626 (-41.97%) |
Filing History |
| 2025-04-04 12:00 pm Sale |
2025-02-18 | 13D | ReShape Lifesciences Inc. RSLS |
Dominion Capital LLC | 1,011 0.760% |
-2,121 (-67.71%) |
Filing History |
| 2025-02-24 3:02 pm Purchase |
2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS |
Leonite Fund I, LP | 8,000 6.100% |
8,000 (New Position) |
Filing History |
| 2025-02-24 11:24 am Purchase |
2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS |
FirstFire Global Opportunities Fund LLC | 8,000 6.100% |
8,000 (New Position) |
Filing History |
| 2025-02-21 5:28 pm Purchase |
2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS |
BIGGER CAPITAL FUND L P | 12,800 9.680% |
12,800 (New Position) |
Filing History |
| 2025-02-21 10:33 am Purchase |
2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS |
CVI Investments, Inc. | 13,785 9.900% |
13,785 (New Position) |
Filing History |
| 2025-01-07 2:52 pm Purchase |
2024-12-27 | 13D | ReShape Lifesciences Inc. RSLS |
Dominion Capital LLC | 3,132 9.900% |
3,132 (New Position) |
Filing History |
| 2024-09-26 4:45 pm Sale |
2024-09-23 | 13G | ReShape Lifesciences Inc. RSLS |
Schneid Yair | 1,496 8.374% |
-201 (-11.84%) |
Filing History |
| 2024-01-16 6:07 pm Purchase |
2024-01-05 | 13G | ReShape Lifesciences Inc. RSLS |
Schneid Yair | 1,697 10.525% |
1,697 (New Position) |
Filing History |
| 2023-03-17 5:01 pm Purchase |
2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS |
Matthew Joseph Nachtrab Revocable Trust 2014 | 92 27.700% |
92 (New Position) |
Filing History |
| 2023-02-15 3:34 pm Purchase |
2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS |
FOLEY & LARDNER | 92 27.700% |
92 (New Position) |
Filing History |
| 2023-02-14 1:24 pm Purchase |
2022-12-31 | 13G | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 18 4.990% |
18 (New Position) |
Filing History |
| 2022-02-14 6:35 pm Purchase |
2021-12-31 | 13G | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 27 9.990% |
15 (+126.96%) |
Filing History |
| 2022-02-14 06:15 am Purchase |
2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS |
INTERWEST PARTNERS X LP | 0 0.000% |
0 (New Position) |
Filing History |
| 2021-06-30 06:16 am Unchanged |
2021-06-29 | 13G | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 12 9.990% |
0 (Unchanged) |
Filing History |
| 2021-06-30 06:10 am Sale |
2021-06-28 | 13D | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 12 9.990% |
-88 (-87.96%) |
Filing History |
| 2021-06-25 4:21 pm Purchase |
2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS |
Armistice Capital, LLC | 100 49.800% |
100 (New Position) |
Filing History |
| 2021-06-21 10:46 am Purchase |
2021-06-16 | 13D | ReShape Lifesciences Inc. RSLS |
DOMAIN PARTERS VII L P | 1 13.000% |
1 (New Position) |
Filing History |